We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue
PURITAN MEDICAL

Download Mobile App




Events

more events
ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
05 Jul 2020 - 08 Jul 2020
Virtual Venue
ESHRE 2020 – 36th Annual Meeting of the European Society of Human Reproduction and Embryology.
06 Jul 2020 - 10 Jul 2020
Virtual Venue
AIDS 2020 - 23rd International AIDS Conference
27 Jul 2020 - 30 Jul 2020
KoreaLab 2020

Image: Eurofins Launches CE-IVD Marked Rapid POC Testing Devices to Identify Past Exposure to COVID-19 in 10 Minutes (Photo courtesy of Eurofins Technologies)

Eurofins Launches CE-IVD Marked Rapid POC Testing Devices to Identify Past Exposure to COVID-19 in 10 Minutes

Eurofins Technologies (Budapest, Hungary) has launched CE-IVD marked rapid point-of-care testing devices to identify a person’s past exposure to COVID-19 (SARS-CoV-2) in only 10 minutes. More...
02 Jul 2020

Real Time RT-PCR Test for COVID-19
Detects 3 SARS-CoV-2 targets in parallel, the targets are recommended by the WHO. No other tests worldwide focuses on 3 targets.
2 controls are included: Showing the sample quality; Extraction and inhibition control.
[LINEAR CHEMICALS, S.L.]
Illustration

T2 Biosystems Launches New COVID-19 Molecular Diagnostic Test

T2 Biosystems, Inc. (Lexington, MA, USA) has completed validation of its COVID-19 molecular diagnostic test, the T2SARS-CoV-2 Panel. The test was developed by T2 Biosystems under a license agreement with the Center of Discovery and Innovation at Hackensack Meridian Health and is being commercially distributed after validation meeting requirements for an Emergency Use Authorization (EUA) request to FDA. More...
02 Jul 2020
Image: Elecsys IL-6 Test (Photo courtesy of Roche)

Roche Secures FDA Emergency Use Authorization for Elecsys IL-6 Test to Identify Severe Inflammatory Response in COVID-19 Patients

Roche (Basel, Switzerland) has secured Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its new Elecsys IL-6 test to help in identifying COVID-19 patients at a high risk of severe inflammatory response. More...
02 Jul 2020
Image: Low levels of bicarbonate in the blood were linked to a higher risk of progression to chronic kidney disease (Photo courtesy of Blood Tests London).

Pediatric CKD Progression Linked to Low Serum Bicarbonate

Metabolic acidosis is a serious electrolyte disorder characterized by an imbalance in the body's acid-base balance. Metabolic acidosis has three main root causes: increased acid production, loss of bicarbonate, and a reduced ability of the kidneys to excrete excess acids. More...
02 Jul 2020
Image: The Chemagic 360 extracts DNA and uses transiently magnetized rods to attract the beads after binding to the nucleic acids (Photo courtesy of PerkinElmer).

Blood Group Locus Contributes to COVID-19 Severity Risk

There is considerable variation in disease behavior among patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). More...
02 Jul 2020
Image: The Chemagic 360 extracts DNA and uses transiently magnetized rods to attract the beads after binding to the nucleic acids (Photo courtesy of PerkinElmer).

Blood Group Locus Contributes to COVID-19 Severity Risk

There is considerable variation in disease behavior among patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). More...
02 Jul 2020
Image: The NF-light (Neurofilament light) ELISA kit allows fast quantification in less than three hours of neurofilament light in cerebrospinal fluid (Photo courtesy of Andreas Nilsson).

Blood Test Could Predict Multiple Sclerosis Progression

Multiple sclerosis (MS) is an immune-mediated neurodegenerative disease of the central nervous system (CNS), with a highly variable inter-individual disease course. As a result, even if using existing clinical prognostic factors, the forecasting of long-term prognosis is often unreliable and imprecise. More...
01 Jul 2020

In Other News

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chemistry
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry News
Events

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

TradeMed.comHospiMedica.com Globetech.net

Archive:

2020
MEDLAB 2020 2019
Medica 2019 AACC 2019 MEDLAB 2019 2018
AACC 2018 MEDLAB 2018 2017
AACC 2017 MEDLAB 2017

 

2016
AACC 2016 2015
AACC 2015 2014
AACC 2014 2013
AACC 2013 2012 AACC
Copyright © 2000-2020 Globetech Media. All rights reserved.
MOBILE | FULL SITE